Dynamin 2 and c-Abl Are Novel Regulators of Hyperoxia-mediated NADPH Oxidase Activation and Reactive Oxygen Species Production in Caveolin-enriched Microdomains of the Endothelium*

Reactive oxygen species (ROS) generation, particularly by the endothelial NADPH oxidase family of proteins, plays a major role in the pathophysiology associated with lung inflammation, ischemia/reperfusion injury, sepsis, hyperoxia, and ventilator-associated lung injury. We examined potential regulators of ROS production and discovered that hyperoxia treatment of human pulmonary artery endothelial cells induced recruitment of the vesicular regulator, dynamin 2, the non-receptor tyrosine kinase, c-Abl, and the NADPH oxidase subunit, p47phox, to caveolin-enriched microdomains (CEMs). Silencing caveolin-1 (which blocks CEM formation) and/or c-Abl expression with small interference RNA inhibited hyperoxia-mediated tyrosine phosphorylation and association of dynamin 2 with p47phox and ROS production. In addition, treatment of human pulmonary artery endothelial cells with dynamin 2 small interfering RNA or the dynamin GTPase inhibitor, Dynasore, attenuated hyperoxia-mediated ROS production and p47phox recruitment to CEMs. Using purified recombinant proteins, we observed that c-Abl tyrosine-phosphorylated dynamin 2, and this phosphorylation increased p47phox/dynamin 2 association (change in the dissociation constant (Kd) from 85.8 to 6.9 nm). Furthermore, exposure of mice to hyperoxia increased ROS production, c-Abl activation, dynamin 2 association with p47phox, and pulmonary leak, events that were attenuated in the caveolin-1 knock-out mouse confirming a role for CEMs in ROS generation. These results suggest that hyperoxia induces c-Abl-mediated dynamin 2 phosphorylation required for recruitment of p47phox to CEMs and subsequent ROS production in lung endothelium.

[1]  Yutong Zhao,et al.  Phospholipase D-mediated Activation of IQGAP1 through Rac1 Regulates Hyperoxia-induced p47phox Translocation and Reactive Oxygen Species Generation in Lung Endothelial Cells* , 2009, Journal of Biological Chemistry.

[2]  M. Gougerot-Pocidalo,et al.  p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases , 2009, Experimental & Molecular Medicine.

[3]  A. Klibanov,et al.  Akt-Mediated Transactivation of the S1P1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids , 2009, Circulation research.

[4]  V. Natarajan,et al.  Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. , 2009, Antioxidants & redox signaling.

[5]  V. Natarajan,et al.  Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells. , 2009, Antioxidants & redox signaling.

[6]  H. Schmidt,et al.  NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. , 2008, Pharmacology & therapeutics.

[7]  A. Sirvent,et al.  Cytoplasmic signalling by the c‐Abl tyrosine kinase in normal and cancer cells , 2008, Biology of the cell.

[8]  R. Arlinghaus,et al.  Activated c-Abl tyrosine kinase in malignant solid tumors , 2008, Oncogene.

[9]  J. M. Robinson Reactive oxygen species in phagocytic leukocytes , 2008, Histochemistry and Cell Biology.

[10]  A. T. Lau,et al.  Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic , 2008, Journal of cellular biochemistry.

[11]  C. Schwencke,et al.  The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium. , 2008, Journal of molecular and cellular cardiology.

[12]  S. Ryter,et al.  Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. , 2008, American journal of respiratory cell and molecular biology.

[13]  G. Hu,et al.  Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[14]  R. Salgia,et al.  CD44 Regulates Hepatocyte Growth Factor-mediated Vascular Integrity , 2007, Journal of Biological Chemistry.

[15]  W. Sessa,et al.  Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice , 2007, The Journal of experimental medicine.

[16]  S. Dudek,et al.  Regulation of Hyperoxia-induced NADPH Oxidase Activation in Human Lung Endothelial Cells by the Actin Cytoskeleton and Cortactin* , 2007, Journal of Biological Chemistry.

[17]  M. Lisanti,et al.  Caveolae and caveolin-1: novel potential targets for the treatment of cardiovascular disease. , 2007, Current pharmaceutical design.

[18]  D. Gutterman,et al.  Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[19]  R. Parton,et al.  The multiple faces of caveolae , 2007, Nature Reviews Molecular Cell Biology.

[20]  Shwu-Fan Ma,et al.  Transactivation of Sphingosine 1-Phosphate Receptors Is Essential for Vascular Barrier Regulation , 2006, Journal of Biological Chemistry.

[21]  T. Mayadas,et al.  Vav Proteins in Neutrophils Are Required for FcγR-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox)1 , 2006, The Journal of Immunology.

[22]  M. Ushio-Fukai Localizing NADPH Oxidase–Derived ROS , 2006, Science's STKE.

[23]  Simon J. Walker,et al.  NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.

[24]  S. Ryu,et al.  The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis , 2006, Nature Cell Biology.

[25]  M. McNiven,et al.  Dynamin as a mover and pincher during cell migration and invasion , 2006, Journal of Cell Science.

[26]  Zhen-Yu Chen,et al.  Reactive oxygen species in vascular wall. , 2006, Cardiovascular & hematological disorders drug targets.

[27]  R. Alexander,et al.  cAbl Tyrosine Kinase Mediates Reactive Oxygen Species– and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy , 2005, Circulation research.

[28]  A. Shah,et al.  NADPH oxidase and endothelial cell function. , 2005, Clinical science.

[29]  R. Alexander,et al.  Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hypertrophy , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[30]  N. Parinandi,et al.  Src-mediated Tyrosine Phosphorylation of p47phox in Hyperoxia-induced Activation of NADPH Oxidase and Generation of Reactive Oxygen Species in Lung Endothelial Cells* , 2005, Journal of Biological Chemistry.

[31]  M. McNiven,et al.  Caveolin-1 interacts directly with dynamin-2. , 2005, Journal of molecular biology.

[32]  Xiang-An Li,et al.  Caveolae, lipid rafts, and vascular disease. , 2005, Trends in cardiovascular medicine.

[33]  D. Schafer Regulating Actin Dynamics at Membranes: A Focus on Dynamin , 2004, Traffic.

[34]  A. Malik,et al.  Role of Src-induced Dynamin-2 Phosphorylation in Caveolae-mediated Endocytosis in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[35]  L. Bourguignon,et al.  CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. , 2004, Experimental cell research.

[36]  M. Lisanti,et al.  The Caveolin genes: from cell biology to medicine , 2004, Annals of medicine.

[37]  Nicole Rusk,et al.  Modulation of Rac localization and function by dynamin. , 2003, Molecular biology of the cell.

[38]  Oliver Hantschel,et al.  Regulation of the c-Abl and Bcr–Abl tyrosine kinases , 2004, Nature Reviews Molecular Cell Biology.

[39]  E. Schiffrin,et al.  c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[40]  C. Mastick,et al.  c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14. , 2003, Cellular signalling.

[41]  J. Zweier,et al.  Viswanathan Natarajan Cells Regulation by Map Kinases in Human Lung Endothelial Hyperoxia-induced Nad(p)h Oxidase Activation And , 2002 .

[42]  L. Stephens,et al.  Regulation of Phosphatidylinositol 3-Kinase Activity and Phosphatidylinositol 3,4,5-Trisphosphate Accumulation by Neutrophil Priming Agents1 , 2002, The Journal of Immunology.

[43]  Giulio Superti‐Furga,et al.  c‐Abl is an effector of Src for growth factor‐induced c‐myc expression and DNA synthesis , 2002, The EMBO journal.

[44]  R. Weichselbaum,et al.  Activation of the Cytoplasmic c-Abl Tyrosine Kinase by Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.

[45]  A. Kazlauskas,et al.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.

[46]  Seymour Reichlin,et al.  Handbook of experimental pharmacology , 1984 .